Follow in September: Alzheimer's disease-can regenerative medicine be the key to understanding it?

According to the Alzheimer's Association ( of Alzheimer ''s Association or ) statistics, in 65 people over the age of, on average every 10 people on the planet 1 Ge suffering from Alzheimer's disease , the number of patients is even more than the United States 5 million

Regenerative therapy for Alzheimer's disease

Genetics, life>

The preclinical neuroscience research of the Florida Center for Regenerative Medicine has been focusing on genetic risk factors associated with the apolipoprotein E ( APOE ) gene

" We found that changing the APOE genotype in peripheral blood can affect brain cognition and the pathology of

This discovery of Mayo Clinic's Florida campus laid the foundation

“ From external studies , we know that young people’s plasma has the ability to restore youth and regeneration for age-related diseases and general symptoms of aging

At present, little is known about the restorative treatment of aging brains

" We learned from neurodevelopmental research that when our brains have greater plasticity and growth capacity, they release specific signals

Create a miniature brain to study Alzheimer's disease

Many obstacles need to be overcome to study Alzheimer's disease.

"The mouse brain is very different from the human brain on the anatomical and molecular levels

Florida Brain Tissue Bank ( Brain Bank ) to provide 5,000 more than autopsy specimens, of which 3,000 copies important resources from Alzheimer's patients, so researchers have been promoting the cause and progression of neurodegeneration related research

Now, researchers have cultivated human miniature brains in laboratory petri dishes, pushing research further forward

" These miniature living brains are grown from cells from Alzheimer's patients

Dr.

"The treatments for early-onset Alzheimer's disease (age of onset less than 65 years old) and late-onset Alzheimer's disease (age of onset over 65 years old) will be different

Dr.